The province of Holguín has included new population groups to the anti-COVID-19 vaccination programs, as part of the extension of immunization among the priorities of the public health sector in Cuba.
Cuban President Miguel Díaz-Canel Bermúdez today highlighted the authorization of emergency use of the anti-Covid-19 Abdala vaccine in children from two to 11 years old approved by the national regulatory entity.
Cuban President Miguel Díaz-Canel today hailed the arrival in Nicaragua of the first load of immunogens developed in the island against Covid-19, to contribute to the health efforts of that Central American nation.
The Cuban Center for State Control of Medicines, Equipment and Medical Devices is evaluating for its registration a drug called NeuroEpo, an innovative product against Alzheimer's disease.
Cuba's Soberana 02 anti-Covid-19 vaccine was recognized by the prestigious U.S. medical journal Annual Review of Medicine, a step towards its possible international homologation.